The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026
Current recommendations to hold these medications before surgery are consensus based
For the peptide research community, this means the landscape is changing, and adapting to that change is not optional
Insulin resistance-mediated dysregulation of carnitine transport Beyond direct transport defects, systemic insulin resistance in DKD significantly exacerbates carnitine metabolic imbalance
L-carnitine buffers excess acetyl-CoA inside the mitochondria by forming acetylcarnitine, which can reduce metabolic stress, support carbohydrate oxidation and improve efficiency during higher exercise intensities
That may sound pie-in-the-sky, But everyone can live healthier lives which will make things better as a society.